(株)免疫生物研究所の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|---|---|---|
| 東証GRT | 医薬品 | 4570/E00986 | Immuno-Biological Laboratories Co.,Ltd. |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|---|---|---|---|---|---|---|---|---|
| 2014/12/12 | 日証協 | 177,340株 | +3.62% | 11,200株 | +433.33% | 188,169株 | +4.56% | 2,300株 | +283.33% |
| 2014/12/05 | 日証協 | 171,140株 | -0.58% | 2,100株 | 0% | 179,969株 | -0.44% | 600株 | -40% |
| 2014/11/28 | 日証協 | 172,140株 | -7.67% | 0株 | -100% | 180,769株 | -3.21% | 1,000株 | -37.5% |
| 2014/11/21 | 日証協 | 186,440株 | -4.85% | 4,500株 | 0% | 186,769株 | -2.66% | 1,600株 | +1500% |
| 2014/11/14 | 日証協 | 195,940株 | -6.58% | 0株 | -100% | 191,869株 | -3.91% | 100株 | -50% |
| 2014/11/07 | 日証協 | 209,740株 | -6.38% | 5,400株 | -18.18% | 199,669株 | -0.29% | 200株 | -67.21% |
| 2014/10/31 | 日証協 | 224,040株 | +0.22% | 6,600株 | +3200% | 200,259株 | +0.2% | 610株 | +1.67% |
| 2014/10/24 | 日証協 | 223,540株 | -1.24% | 200株 | -94.01% | 199,859株 | -0.15% | 600株 | -91.18% |
| 2014/10/17 | 日証協 | 226,340株 | +0.35% | 3,340株 | +108.75% | 200,159株 | +3.52% | 6,800株 | +223.81% |
| 2014/10/10 | 日証協 | 225,540株 | -1.91% | 1,600株 | -84.31% | 193,359株 | -0.62% | 2,100株 | -88.01% |
| 2014/10/03 | 日証協 | 229,940株 | +2.63% | 10,200株 | +500% | 194,559株 | -1.02% | 17,511株 | +356.02% |
| 2014/09/26 | 日証協 | 224,040株 | -0.44% | 1,700株 | -70.69% | 196,559株 | -0.71% | 3,840株 | +22.29% |
| 2014/09/19 | 日証協 | 225,040株 | +2.52% | 5,800株 | -81.76% | 197,959株 | +1.04% | 3,140株 | -80.62% |
| 2014/09/12 | 日証協 | 219,500株 | +7.7% | 31,800株 | +120.83% | 195,919株 | +2.89% | 16,200株 | -15.62% |
| 2014/09/05 | 日証協 | 203,800株 | -3% | 14,400株 | +453.85% | 190,419株 | -0.84% | 19,200株 | +214.75% |
| 2014/08/29 | 日証協 | 210,100株 | -3.76% | 2,600株 | 0% | 192,029株 | -0.72% | 6,100株 | +190.48% |
| 2014/08/22 | 日証協 | 218,300株 | 0% | 0株 | -100% | 193,429株 | +0.47% | 2,100株 | -25% |
| 2014/08/15 | 日証協 | 218,300株 | +2.06% | 4,400株 | 0% | 192,529株 | +2.12% | 2,800株 | +33.33% |
| 2014/08/08 | 日証協 | 213,900株 | -2.46% | 0株 | -100% | 188,529株 | -0.79% | 2,100株 | +5% |
※株式分割は考慮していませんのでご注意ください。